Robert Wood Johnson Medical School researcher receives fellowship for work in Canavan Disease

Scott McPhee, PhD, of Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey in Camden, has been selected to receive the first Canavan Disease Clinical Research Training Fellowship which is co-sponsored by the Canavan Foundation and the American Academy of Neurology Foundation.

The Canavan Disease Clinical Research Training Fellowship supports research toward the cause, treatment or cure of Canavan disease, a rare and fatal genetic disorder affecting the myelin sheath that insulates and protects nerves and the brain. The two-year fellowship will provide McPhee with $50,000 each year, plus a stipend for tuition reimbursement.

The Canavan Foundation's mission is to help prevent Canavan disease through education and testing and to support research efforts, which have yet to find an effective therapy. Children with Canavan disease cannot crawl or walk, may suffer from seizures or mental retardation, and cannot perform activities of daily living. Canavan disease generally results in death by 10 years of age. For more information about the Canavan Foundation, visit www.canavanfoundation.org.

McPhee plans to examine the development and genetic regulation of myelinating cells called oligodendrocytes, which form the white matter in the brain.

"I am very grateful that I have been honored with this grant, and I plan to make the very most out of this wonderful opportunity," said McPhee, who works in the Cell & Gene Therapy Center at the Medical School.

"My objectives are to determine the underlying disease mechanism in Canavan disease, and to improve our understanding of how the brain normally develops," said McPhee. "The research project will examine how certain cells in the brain develop in the setting of Canavan disease, compared to the normal fetal or newborn brain."

McPhee will be honored during the American Academy of Neurology 56th Annual M

Contact: Marilee Reu
American Academy of Neurology

Page: 1 2

Related medicine news :

1. GSA bestows Robert W. Kleemeier Award to University of Texas Health Science Centers Smith
2. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
3. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers
4. Medically supervised drug injection facilities safer for users
5. Medical molecules designed to respond to visible light that can penetrate tissue
6. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
7. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
8. New data on Orqis Medicals Cancion CRS to be reported at ACC
9. Medical technologies may hinder rather than help newborn survival
10. Medical meeting to feature research findings and disease prevention and health promotion sessions
11. LA BioMed Medical/Research briefs January 2005

Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology:
Cached News: